Curian Capital’s AbbVie ABBV Stock Holding History

Curian Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-95,140	Closed	-$5.64M	–	5
2015 Q4	$5.64M	Sell	95,140 -162,877	-63%	-$9.38M	0.42%	43
2015 Q3	$14M	Sell	258,017 -169,372	-40%	-$11M	0.37%	54
2015 Q2	$28.7M	Sell	427,389 -1,505	-0.4%	-$98.3K	0.48%	39
2015 Q1	$25.1M	Sell	428,894 -65,502	-13%	-$3.96M	0.42%	46
2014 Q4	$32.4M	Buy	494,396 +36,830	+8%	+$2.32M	0.55%	38
2014 Q3	$26.4M	Buy	457,566 +247,664	+118%	+$13.7M	0.47%	44
2014 Q2	$11.8M	Buy	209,902 +2,298	+1%	+$121K	0.21%	110
2014 Q1	$10.7M	Sell	207,604 -14,098	-6%	-$713K	0.19%	122
2013 Q4	$11.7M	Buy	221,702 +4,714	+2%	+$232K	0.21%	118
2013 Q3	$9.71M	Buy	216,988 +2,505	+1%	+$111K	0.17%	129
2013 Q2	$8.87M	Buy	+214,483	New	+$9.38M	0.16%	125

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Curian Capital's ABBV Position: Q1 2016 in Review

Curian Capital sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 95,140 shares — an estimated $5.64M sold.

Curian Capital first reported a position in ABBV in Q2 2013 and held it in 11 quarters. The position peaked at $32.4M in Q4 2014. 1,638 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Curian Capital reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
Curian Capital sold 95,140 AbbVie shares in Q1 2016, an estimated $5.64M.
Curian Capital first reported a position in AbbVie in Q2 2013 and held it in 11 quarters.
Curian Capital's AbbVie position peaked at $32.4M in Q4 2014.
1,638 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.